The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Rheumatology Drugs-Global Market Insights and Sales Trends 2025

Rheumatology Drugs-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1839691

No of Pages : 102

Ask Your Query

Synopsis

The global Rheumatology Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Rheumatology Drugs in various end use industries. The expanding demands from the Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, are propelling Rheumatology Drugs market. Disease Modifying Anti-rheumatic Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nonsteroidal Anti-inflammatory Drugs segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rheumatology Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Rheumatology Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Rheumatology Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rheumatology Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Rheumatology Drugs covered in this report include Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer and Bristol-Myers Squibb Company, etc.

The global Rheumatology Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Takeda Pharmaceutical
  • Sanofi
  • Genentech
  • Novartis
  • Janssen Biotech
  • Amgen
  • AbbVie
  • Pfizer
  • Bristol-Myers Squibb Company
  • Merck & Co.

Global Rheumatology Drugs market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Rheumatology Drugs market, Segment by Type:

  • Disease Modifying Anti-rheumatic Drugs
  • Nonsteroidal Anti-inflammatory Drugs
  • Corticosteroids
  • Uric Acid Drugs
  • Others

Global Rheumatology Drugs market, by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Rheumatology Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Rheumatology Drugs
1.1 Rheumatology Drugs Market Overview
1.1.1 Rheumatology Drugs Product Scope
1.1.2 Rheumatology Drugs Market Status and Outlook
1.2 Global Rheumatology Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Rheumatology Drugs Market Size by Region (2018-2029)
1.4 Global Rheumatology Drugs Historic Market Size by Region (2018-2023)
1.5 Global Rheumatology Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Rheumatology Drugs Market Size (2018-2029)
1.6.1 North America Rheumatology Drugs Market Size (2018-2029)
1.6.2 Europe Rheumatology Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Rheumatology Drugs Market Size (2018-2029)
1.6.4 Latin America Rheumatology Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Rheumatology Drugs Market Size (2018-2029)
2 Rheumatology Drugs Market by Type
2.1 Introduction
2.1.1 Disease Modifying Anti-rheumatic Drugs
2.1.2 Nonsteroidal Anti-inflammatory Drugs
2.1.3 Corticosteroids
2.1.4 Uric Acid Drugs
2.1.5 Others
2.2 Global Rheumatology Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Rheumatology Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Rheumatology Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Rheumatology Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Rheumatology Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Rheumatology Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Rheumatology Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Rheumatology Drugs Revenue Breakdown by Type (2018-2029)
3 Rheumatology Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Rheumatology Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Rheumatology Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Rheumatology Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Rheumatology Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Rheumatology Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Rheumatology Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Rheumatology Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Rheumatology Drugs Revenue Breakdown by Application (2018-2029)
4 Rheumatology Drugs Competition Analysis by Players
4.1 Global Rheumatology Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2022)
4.3 Date of Key Players Enter into Rheumatology Drugs Market
4.4 Global Top Players Rheumatology Drugs Headquarters and Area Served
4.5 Key Players Rheumatology Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Rheumatology Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Takeda Pharmaceutical
5.1.1 Takeda Pharmaceutical Profile
5.1.2 Takeda Pharmaceutical Main Business
5.1.3 Takeda Pharmaceutical Rheumatology Drugs Products, Services and Solutions
5.1.4 Takeda Pharmaceutical Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Takeda Pharmaceutical Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Rheumatology Drugs Products, Services and Solutions
5.2.4 Sanofi Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Genentech
5.3.1 Genentech Profile
5.3.2 Genentech Main Business
5.3.3 Genentech Rheumatology Drugs Products, Services and Solutions
5.3.4 Genentech Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Rheumatology Drugs Products, Services and Solutions
5.4.4 Novartis Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Janssen Biotech
5.5.1 Janssen Biotech Profile
5.5.2 Janssen Biotech Main Business
5.5.3 Janssen Biotech Rheumatology Drugs Products, Services and Solutions
5.5.4 Janssen Biotech Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Janssen Biotech Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Rheumatology Drugs Products, Services and Solutions
5.6.4 Amgen Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 AbbVie
5.7.1 AbbVie Profile
5.7.2 AbbVie Main Business
5.7.3 AbbVie Rheumatology Drugs Products, Services and Solutions
5.7.4 AbbVie Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 AbbVie Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Rheumatology Drugs Products, Services and Solutions
5.8.4 Pfizer Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Recent Developments
5.9 Bristol-Myers Squibb Company
5.9.1 Bristol-Myers Squibb Company Profile
5.9.2 Bristol-Myers Squibb Company Main Business
5.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Products, Services and Solutions
5.9.4 Bristol-Myers Squibb Company Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Bristol-Myers Squibb Company Recent Developments
5.10 Merck & Co.
5.10.1 Merck & Co. Profile
5.10.2 Merck & Co. Main Business
5.10.3 Merck & Co. Rheumatology Drugs Products, Services and Solutions
5.10.4 Merck & Co. Rheumatology Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Merck & Co. Recent Developments
6 North America
6.1 North America Rheumatology Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Rheumatology Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Rheumatology Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Rheumatology Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Rheumatology Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Rheumatology Drugs Market Dynamics
11.1 Rheumatology Drugs Industry Trends
11.2 Rheumatology Drugs Market Drivers
11.3 Rheumatology Drugs Market Challenges
11.4 Rheumatology Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock